Boehringer Ingelheim voluntarily withdraws its clobutinol containingWebWire (press release), GA - 1 hour agoBoehringer Ingelheim has decided in accordance with the competent authorities in Germany to voluntarily withdraw its clobutinol hydrochloride containing …
Read full story
Boehringer Ingelheim recalls clobutinol productsIn-PharmaTechnologist.com, UK - 2 hours agoBy Katrina Megget 03/09/2007 - Boehringer Ingelheim is voluntarily recalling all worldwide products containing clobutinol hydrochloride, which has been on …
Read full story
Boehringer Ingelheim recalls Silomat cough medicine on risk of …Forbes, NY - Aug 31, 2007FRANKFURT (Thomson Financial) - Boehringer Ingelheim GmbH said it is recalling most of its cough medication Silomat, as it may lead to cardiac arrhythmia in …
Read full story
Product RecallsWashington Post, United States - Sep 1, 2007DETAILS: Boehringer Ingelheim is recalling its Silomat cough medicine. DEFECT: One of the drug's ingredients, clobutinol, led to a higher risk for heart …
Read full story
Patent Reforms Fall Short Of What State Firms NeedHartford Courant, United States - Aug 29, 2007Our companies have much in common: Boehringer Ingelheim and Pfizer discover, develop, manufacture and market biotechnology and pharmaceutical products that …
Read full story
Boehringer Ingelheim Offers a Licence to Apotex to Export BI's …PharmaLive.com (press release), PA - Aug 22, 200722 /CNW/ - Boehringer Ingelheim has offered the Canadian generic pharmaceutical manufacturer Apotex Inc. a royalty free, voluntary licence to manufacture …
Read full story
Germany bans use of cough drugs with clobutinolTherapeutics Daily (subscription) (press release), PA - Sep 1, 2007The decision came after new findings from a clinical study by unlisted Boehringer Ingelheim suggested that a potential risk of cardiac arrhythmia …
Read full story
Boehringer Ingelheim Announces First International Head-to-head …Medical News Today (press release), UK - Aug 6, 2007Boehringer Ingelheim GmbH announced today that enrollment of the POTENT study will begin in August 2007. POTENT will compare the efficacy and safety of …
Read full story
YLE NewsCough Medicines Withdrawn From MarketYLE News, Finland - Aug 31, 2007According to the medical director of Boehringer Ingelheim Finland, Tapio Kerttula, the risk of developing arrhythmia from the medication is, however, …
Read full story
Prodest Study Shows Many Parkinson’s Disease Patients Continue to …PharmaLive.com (press release), PA - Aug 28, 2007This release is from the Corporate Headquarters of Boehringer Ingelheim and is intended for all international markets. This being the case, please be aware …Boehringer Ingelheim - Google News
Read full story
Aptivus (tipranavir) Demonstrates Potent And Durable Treatment …Medical News Today (press release), UK - 8 hours agoBoehringer Ingelheim recently announced the initiation of the SPRING study, which will be one of the largest racially and gender diverse international …
Read full story
Boehringer Ingelheim Launches National Educational Initiative to …PR Newswire (press release), NY - Jul 18, 2007To help drive understanding and disease awareness among physicians and people with RLS, Boehringer Ingelheim Pharmaceuticals, Inc. has launched an …
Read full story
Key business with prescription medicines continues to boost growth …WebWire (press release), GA - Jul 30, 2007The pharmaceutical company Boehringer Ingelheim again posted good business results for the first six months of 2007. The company grew by 2.1% in euro terms …
Read full story
Documentum upgrade extends open source supportComputerworld, MA - Jul 31, 2007Jorg Werner, manager of Document Management for Ingelheim, Germany-based Boehringer Ingelheim Pharma GmbH, however, said another significant new D6 feature …
Read full story
Milestone payment for BioFocusBusiness Weekly, UK - Aug 1, 2007… Chesterford-based BioFocus DPI, has received a milestone payment in its autoimmune discovery research collaboration with Boehringer Ingelheim. …
Read full story
Boehringer Ingelheim announces first international head-to-head …PipelineReview.com (press release), Spain - Jul 25, 2007INGELHEIM, Germany | July 24, 2007 | Boehringer Ingelheim GmbH announced today that enrollment of the POTENT study will begin in August 2007. …
Read full story
Weston ForumDavid Weinstock Westonite elected chairman of bar association sectionWeston Forum, CT - 3 hours agoWestonite David S. Weinstock, a director and senior regulatory counsel for Boehringer Ingelheim Pharmaceuticals Inc. in Ridgefield, has been named chairman …
Read full story
New Spiriva® Respimat® inhaler completes European approval process …WebWire (press release), GA - 13 hours agoBoehringer Ingelheim and Pfizer today announced successful completion of the approval process for authorisation to market Spiriva® Respimat® in the European …
Read full story
Caliper Life Sciences Develops Customized Transfection System for …CNNMoney.com - 17 hours agoCaliper recently created a unique solution for Boehringer Ingelheim that automates aspects of Baculovirus expression. To develop the system for Boehringer …
Read full story
Boehringer's H1 profit down on generic competitionTherapeutics Daily (subscription) (press release), PA - Jul 26, 2007FRANKFURT (Reuters) - Boehringer Ingelheim's first-half operating profit fell 3.1 percent because of generic competition to its anti-rheumatic drug Mobic …
Read full story